Low  	Low  	 JJ	O
tissue  	tissue  	 NN	O
oxygen  	oxygen  	 NN	O
saturation  	saturation  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
early  	early  	 JJ	O
goal-directed  	goal-directed  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
worse  	worse  	 JJR	B-NP
outcome  	outcome  	 NN	I-NP
in  	in  	 IN	O
critically  	critically  	 RB	O
ill  	ill  	 JJ	O
patients  	patients  	 NNS	O
The  	The  	 DT	O
prognostic  	prognostic  	 JJ	B-NP
value  	value  	 NN	I-NP
of  	of  	 IN	I-NP
continuous  	continuous  	 JJ	I-NP
monitoring  	monitoring  	 NN	I-NP
of  	of  	 IN	O
tissue  	tissue  	 NN	O
oxygen  	oxygen  	 NN	O
saturation  	saturation  	 NNS	O
( 	( 	 -LRB-	O
StO2 	StO2 	 NNP	B-NP
)  	)  	 -RRB-	O
during  	during  	 IN	O
early  	early  	 JJ	O
goal-directed  	goal-directed  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
of  	of  	 IN	O
critically  	critically  	 RB	O
ill  	ill  	 JJ	O
patients  	patients  	 NNS	O
has  	has  	 VBZ	O
not  	not  	 RB	O
been  	been  	 VBN	O
investigated 	investigated 	 VBN	O
.  	.  	 .	O
We  	We  	 PRP	O
conducted  	conducted  	 VBD	O
this  	this  	 DT	O
prospective  	prospective  	 JJ	B-NP
study  	study  	 NN	I-NP
to  	to  	 TO	O
test  	test  	 VB	O
the  	the  	 DT	O
hypothesis  	hypothesis  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
persistence  	persistence  	 NN	O
of  	of  	 IN	O
low  	low  	 JJ	O
StO2  	StO2  	 CD	B-NP
levels  	levels  	 NNS	I-NP
following  	following  	 VBG	O
intensive  	intensive  	 JJ	B-NP
care  	care  	 NN	I-NP
admission  	admission  	 NN	I-NP
is  	is  	 VBZ	O
related  	related  	 VBN	O
to  	to  	 TO	O
adverse  	adverse  	 JJ	O
outcome 	outcome 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
followed  	followed  	 VBD	O
22  	22  	 CD	O
critically  	critically  	 CD	O
ill  	ill  	 JJ	O
patients  	patients  	 NNS	O
admitted  	admitted  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
lactate  	lactate  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
> 	> 	 CD	O
3  	3  	 CD	O
mmol 	mmol 	 CD	B-NP
/ 	/ 	 CD	I-NP
l 	l 	 CD	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Near-infrared  	Near-infrared  	 JJ	B-NP
spectroscopy  	spectroscopy  	 NNS	I-NP
( 	( 	 -LRB-	O
NIRS 	NIRS 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
measure  	measure  	 VB	O
the  	the  	 DT	O
thenar  	thenar  	 JJ	B-NP
eminence  	eminence  	 JJ	I-NP
StO2  	StO2  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
StO2  	StO2  	 CD	B-NP
increase  	increase  	 NN	I-NP
( 	( 	 -LRB-	O
RincStO2 	RincStO2 	 NNP	B-NP
)  	)  	 -RRB-	O
after  	after  	 IN	O
a  	a  	 DT	O
vascular  	vascular  	 JJ	B-NP
occlusion  	occlusion  	 JJ	I-NP
test 	test 	 NN	I-NP
.  	.  	 .	O
NIRS  	NIRS  	 NNP	B-NP
dynamic  	dynamic  	 JJ	I-NP
measurements  	measurements  	 NNS	I-NP
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
at  	at  	 IN	O
intensive  	intensive  	 JJ	B-NP
care  	care  	 NN	I-NP
admission  	admission  	 NN	I-NP
and  	and  	 CC	O
each  	each  	 DT	O
2-hour  	2-hour  	 JJ	O
interval  	interval  	 NN	O
during  	during  	 IN	O
8  	8  	 CD	O
hours  	hours  	 NNS	O
of  	of  	 IN	O
resuscitation 	resuscitation 	 NN	B-NP
.  	.  	 .	O
All  	All  	 DT	O
repeated  	repeated  	 VBN	B-NP
StO2  	StO2  	 CD	I-NP
measurements  	measurements  	 NNS	I-NP
were  	were  	 VBD	O
further  	further  	 RB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
Sequential  	Sequential  	 NNP	B-NP
Organ  	Organ  	 NNP	I-NP
Failure  	Failure  	 NNP	I-NP
Assessment  	Assessment  	 NNP	I-NP
( 	( 	 -LRB-	O
SOFA 	SOFA 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
Acute  	Acute  	 NNP	B-NP
Physiology  	Physiology  	 NNP	I-NP
and  	and  	 CC	I-NP
Chronic  	Chronic  	 NNP	I-NP
Health  	Health  	 NNP	I-NP
Evaluation  	Evaluation  	 NNP	I-NP
( 	( 	 -LRB-	O
APACHE 	APACHE 	 NNP	B-NP
)  	)  	 -RRB-	O
II  	II  	 NNP	O
and  	and  	 CC	O
hemodynamic  	hemodynamic  	 JJ	B-NP
physiological  	physiological  	 JJ	I-NP
variables 	variables 	 NNS	I-NP
:  	:  	 :	O
heart  	heart  	 NN	B-NP
rate  	rate  	 NN	I-NP
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
mean  	mean  	 VBP	B-NP
arterial  	arterial  	 JJ	I-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
MAP 	MAP 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
central  	central  	 JJ	O
venous  	venous  	 JJ	B-NP
oxygen  	oxygen  	 NN	I-NP
saturation  	saturation  	 NNS	I-NP
( 	( 	 -LRB-	O
ScvO2 	ScvO2 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
parameters  	parameters  	 NNS	O
of  	of  	 IN	O
peripheral  	peripheral  	 JJ	B-NP
circulation  	circulation  	 NN	I-NP
( 	( 	 -LRB-	O
physical  	physical  	 JJ	B-NP
examination  	examination  	 NN	I-NP
and  	and  	 CC	O
peripheral  	peripheral  	 JJ	B-NP
flow  	flow  	 NN	I-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
PFI 	PFI 	 NNP	B-NP
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Twelve  	Twelve  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
admitted  	admitted  	 VBN	O
with  	with  	 IN	O
low  	low  	 JJ	O
StO2  	StO2  	 CD	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
StO2  	StO2  	 CD	B-NP
< 	< 	 SYM	O
70 	70 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	O
scores  	scores  	 NNS	O
for  	for  	 IN	O
SOFA  	SOFA  	 NNP	O
and  	and  	 CC	O
APACHE  	APACHE  	 NNP	O
II  	II  	 NNP	O
scores  	scores  	 NNS	O
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
persisted  	persisted  	 VBD	O
with  	with  	 IN	O
low  	low  	 JJ	O
StO2  	StO2  	 CD	B-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
10 	10 	 CD	O
)  	)  	 -RRB-	O
than  	than  	 IN	O
in  	in  	 IN	O
those  	those  	 DT	O
who  	who  	 WP	O
exhibited  	exhibited  	 VBP	O
normal  	normal  	 JJ	B-NP
StO2  	StO2  	 CD	I-NP
levels  	levels  	 NNS	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
12 	12 	 CD	O
)  	)  	 -RRB-	O
at  	at  	 IN	O
8  	8  	 CD	O
hours  	hours  	 NNS	O
after  	after  	 IN	O
the  	the  	 DT	O
resuscitation  	resuscitation  	 JJ	B-NP
period  	period  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
;  	;  	 :	O
median  	median  	 JJ	B-NP
( 	( 	 -LRB-	O
interquartile  	interquartile  	 JJ	B-NP
range 	range 	 NN	I-NP
) 	) 	 -RRB-	O
:  	:  	 :	O
SOFA 	SOFA 	 NNP	O
,  	,  	 ,	O
8  	8  	 CD	O
( 	( 	 -LRB-	O
7  	7  	 CD	O
to  	to  	 TO	O
11 	11 	 CD	O
)  	)  	 -RRB-	O
vs.  	vs.  	 IN	O
5  	5  	 CD	O
( 	( 	 -LRB-	O
3  	3  	 CD	O
to  	to  	 TO	O
8 	8 	 CD	O
) 	) 	 -RRB-	O
;  	;  	 :	O
APACHE  	APACHE  	 NNP	O
II 	II 	 NNP	O
,  	,  	 ,	O
32 	32 	 CD	B-NP
( 	( 	 -LRB-	I-NP
24  	24  	 CD	I-NP
to  	to  	 TO	I-NP
33 	33 	 CD	I-NP
)  	)  	 -RRB-	I-NP
vs.  	vs.  	 IN	O
19  	19  	 CD	O
( 	( 	 -LRB-	O
15  	15  	 CD	O
to  	to  	 TO	O
25 	25 	 CD	O
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
relationship  	relationship  	 NN	B-NP
between  	between  	 IN	O
StO2  	StO2  	 NNP	B-NP
and  	and  	 CC	O
mean  	mean  	 VB	O
global  	global  	 JJ	O
hemodynamic  	hemodynamic  	 JJ	B-NP
variables  	variables  	 NNS	I-NP
( 	( 	 -LRB-	O
HR 	HR 	 NNP	B-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.26 	0.26 	 CD	O
;  	;  	 :	O
MAP 	MAP 	 NNP	O
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.51 	0.51 	 CD	O
;  	;  	 :	O
ScvO2 	ScvO2 	 CD	B-NP
,  	,  	 ,	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.11 	0.11 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
was  	was  	 VBD	O
a  	a  	 DT	O
strong  	strong  	 JJ	O
association  	association  	 NN	O
between  	between  	 IN	O
StO2  	StO2  	 CD	B-NP
with  	with  	 IN	O
clinical  	clinical  	 JJ	B-NP
abnormalities  	abnormalities  	 NN	I-NP
of  	of  	 IN	I-NP
peripheral  	peripheral  	 JJ	I-NP
perfusion  	perfusion  	 NNS	I-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.004 	0.004 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
PFI  	PFI  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.005 	0.005 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
RincStO2  	RincStO2  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.002 	0.002 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
persistence  	persistence  	 NN	O
of  	of  	 IN	O
low  	low  	 JJ	O
StO2  	StO2  	 CD	B-NP
values  	values  	 NNS	I-NP
was  	was  	 VBD	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
low  	low  	 JJ	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
lactate  	lactate  	 JJ	B-NP
decrease  	decrease  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
;  	;  	 :	O
median  	median  	 JJ	B-NP
( 	( 	 -LRB-	O
interquartile  	interquartile  	 JJ	B-NP
range 	range 	 NN	I-NP
) 	) 	 -RRB-	O
:  	:  	 :	O
33 	33 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
12  	12  	 CD	O
to  	to  	 TO	O
43 	43 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
vs.  	vs.  	 IN	O
43 	43 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
30  	30  	 CD	O
to  	to  	 TO	O
54 	54 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
found  	found  	 VBD	O
that  	that  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
consistently  	consistently  	 RB	O
exhibited  	exhibited  	 VBN	O
low  	low  	 JJ	O
StO2  	StO2  	 CD	B-NP
levels  	levels  	 NNS	I-NP
following  	following  	 VBG	O
an  	an  	 DT	O
initial  	initial  	 JJ	O
resuscitation  	resuscitation  	 NN	B-NP
had  	had  	 VBD	O
significantly  	significantly  	 RB	O
worse  	worse  	 JJR	B-NP
organ  	organ  	 NN	I-NP
failure  	failure  	 NN	I-NP
than  	than  	 IN	O
did  	did  	 VBD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
normal  	normal  	 JJ	B-NP
StO2  	StO2  	 CD	I-NP
values 	values 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
found  	found  	 VBD	O
that  	that  	 IN	O
StO2  	StO2  	 CD	B-NP
changes  	changes  	 NNS	I-NP
had  	had  	 VBD	O
no  	no  	 DT	O
relationship  	relationship  	 NN	B-NP
with  	with  	 IN	O
global  	global  	 JJ	O
hemodynamic  	hemodynamic  	 JJ	B-NP
variables 	variables 	 NNS	I-NP
.  	.  	 .	O
